Method Of Treating Lung Adenocarcinoma

Patent No. EP3134084 (titled "Method Of Treating Lung Adenocarcinoma") was filed by Exelixis on Apr 27, 2015. The application was issued on Mar 17, 2021.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
GENERICS UK	Dec 16, 2021	TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Nov 13, 2023
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Nov 13, 2023
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 28, 2023
Advice of delivery
Jul 28, 2023
Decision revoking the European patent
Jul 28, 2023
Decision revoking the European patent
Jul 28, 2023
Transmittal of decision / summons - opposition
Jul 28, 2023
Transmittal of decision / summons - opposition
Jul 26, 2023
Brief communication - Opposition proceedings
Jul 21, 2023
(Electronic) Receipt
Jul 21, 2023
Brief communication - Opposition proceedings
Jul 21, 2023
Letter accompanying subsequently filed items
Jul 21, 2023
Request for revocation of patent
Jul 18, 2023
(Electronic) Receipt
Jul 18, 2023
(Electronic) Receipt
Jul 18, 2023
Letter accompanying subsequently filed items
Jul 18, 2023
Letter accompanying subsequently filed items
Jul 18, 2023
Written submission in preparation to/during oral proceedings
Nov 29, 2022
Notification concerning the date of oral proceedings
Nov 29, 2022
Notification concerning the date of oral proceedings
Oct 28, 2022
Advice of delivery
Oct 28, 2022
Annex to the communication - opposition
Oct 28, 2022
Information concerning oral proceedings
Oct 28, 2022
Scanned annex to a communication - opposition procedure
Oct 28, 2022
Summons to attend oral proceedings
Oct 28, 2022
Summons to attend oral proceedings
Oct 28, 2022
Transmittal of decision / summons - opposition
Oct 28, 2022
Transmittal of decision / summons - opposition
May 27, 2022
Brief communication - Opposition proceedings
May 20, 2022
(Electronic) Receipt
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure
May 20, 2022
Auxiliary request during Opposition procedure - 01
May 20, 2022
Auxiliary request during Opposition procedure - 02
May 20, 2022
Auxiliary request during Opposition procedure - 03
May 20, 2022
Auxiliary request during Opposition procedure - 04
May 20, 2022
Auxiliary request during Opposition procedure - 05
May 20, 2022
Auxiliary request during Opposition procedure - 06
May 20, 2022
Auxiliary request during Opposition procedure - 07
May 20, 2022
Citation in opposition procedure - 016
May 20, 2022
Citation in opposition procedure - 017
May 20, 2022
Citation in opposition procedure - 018
May 20, 2022
Citation in opposition procedure - 019
May 20, 2022
Citation in opposition procedure - 020
May 20, 2022
Citation in opposition procedure - 021
May 20, 2022
Consolidated list of cited opposition documents
May 20, 2022
Letter accompanying subsequently filed items
May 20, 2022
Main request during Opposition procedure
May 20, 2022
Main request during Opposition procedure
May 20, 2022
Reply of the patent proprietor to the notice(s) of opposition
Jan 11, 2022
Communication of a notice of opposition and request to file observations
Jan 11, 2022
Notice of further oppositions to opponent(s)
Dec 21, 2021
Communication of a notice of opposition - first information to patent proprietor
Dec 16, 2021
(Electronic) Receipt
Dec 16, 2021
Citation in opposition procedure - 001
Dec 16, 2021
Citation in opposition procedure - 002
Dec 16, 2021
Citation in opposition procedure - 003
Dec 16, 2021
Citation in opposition procedure - 004
Dec 16, 2021
Citation in opposition procedure - 005
Dec 16, 2021
Citation in opposition procedure - 006
Dec 16, 2021
Citation in opposition procedure - 007
Dec 16, 2021
Citation in opposition procedure - 008
Dec 16, 2021
Citation in opposition procedure - 009
Dec 16, 2021
Citation in opposition procedure - 010
Dec 16, 2021
Citation in opposition procedure - 011
Dec 16, 2021
Citation in opposition procedure - 012
Dec 16, 2021
Citation in opposition procedure - 013
Dec 16, 2021
Citation in opposition procedure - 014
Dec 16, 2021
Citation in opposition procedure - 015
Dec 16, 2021
Notice of opposition
Dec 16, 2021
Notice of opposition
Mar 29, 2021
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 18, 2021
Decision to grant a European patent
Feb 5, 2021
Communication of the registration of a transfer or change of name and/or address
Feb 1, 2021
(Electronic) Receipt
Feb 1, 2021
Filing of the translations of the claims
Feb 1, 2021
French translation of claims
Feb 1, 2021
German translation of the claims
Feb 1, 2021
Letter accompanying subsequently filed items
Sep 21, 2020
Bibliographic data of the European patent application
Sep 21, 2020
Communication about intention to grant a European patent
Sep 21, 2020
Intention to grant (signatures)
Sep 21, 2020
Text intended for grant (clean copy)
Sep 21, 2020
Text intended for grant (sequence listing)
Sep 21, 2020
Text intended for grant (version for approval)
Aug 10, 2020
Decision to allow further processing
Jun 19, 2020
(Electronic) Receipt
Jun 19, 2020
Amended description with annotations
Jun 19, 2020
Description
Jun 19, 2020
Letter accompanying subsequently filed items
Jun 19, 2020
Request for further processing
Apr 9, 2020
Application deemed to be withdrawn ( translations of claims/payment missing)
Dec 4, 2019
Communication of amended entries concerning the representative
Nov 28, 2019
Submission concerning change of applicant's representative
Oct 24, 2019
Bibliographic data of the European patent application
Oct 24, 2019
Communication about intention to grant a European patent
Oct 24, 2019
Intention to grant (signatures)
Oct 24, 2019
Text intended for grant (clean copy)
Oct 24, 2019
Text intended for grant (sequence listing)
Oct 24, 2019
Text intended for grant (version for approval)
Feb 4, 2019
(Electronic) Receipt
Feb 4, 2019
Amended description with annotations
Feb 4, 2019
Description
Feb 4, 2019
Letter accompanying subsequently filed items
Feb 4, 2019
Reply to communication from the Examining Division
Dec 4, 2018
Grant of extension of time limit (examination procedure)
Nov 28, 2018
(Electronic) Receipt
Nov 28, 2018
Letter accompanying subsequently filed items
Nov 28, 2018
Request for extension of time limit to communication from the Examining Division
Jul 23, 2018
Annex to the communication
Jul 23, 2018
Communication from the Examining Division
Jul 16, 2018
Examination started
Oct 30, 2017
Decision to allow further processing
Oct 18, 2017
(Electronic) Receipt
Oct 18, 2017
Amended claims filed after receipt of (European) search report
Oct 18, 2017
Amended claims with annotations
Oct 18, 2017
Amendments received before examination
Oct 18, 2017
Letter accompanying subsequently filed items
Aug 8, 2017
Application deemed to be withdrawn (non-reply to Written Opinion)
Feb 10, 2017
Invitation to indicate correct address of inventor
Feb 1, 2017
Notification on forthcoming publication of bibliographic data
Jan 30, 2017
Letter which had not been notified
Dec 21, 2016
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Dec 16, 2016
Communication to designated inventor
Dec 16, 2016
Communication to designated inventor
Nov 23, 2016
(Electronic) Receipt
Nov 23, 2016
Request for entry into the European phase
Nov 23, 2016
Submission concerning representation
Nov 7, 2016
Copy of the international preliminary report on patentability
Oct 11, 2016
Information on entry into European phase
Nov 16, 2015
Priority document (electronically transmitted)
Oct 29, 2015
Converted Sequence Listing
Oct 29, 2015
Copy of the international search report
Oct 29, 2015
Published international application - A1
Aug 7, 2015
ISR: cited documents
Aug 6, 2015
Written opinion of the ISA, boxes No. I to VIII
Aug 6, 2015
Written opinion of the ISA, cover sheet
Aug 6, 2015
Written opinion of the ISA, supplemental box
Jul 15, 2015
Notification of the recording of a change
Jul 6, 2015
Annex
May 7, 2015
Abstract
May 7, 2015
Annex
May 7, 2015
Annex
May 7, 2015
Claims
May 7, 2015
Description
May 7, 2015
Drawings
May 7, 2015
Submission concerning representation

EP3134084

EXELIXIS

Application Number: EP15721100A
Filing Date: Apr 27, 2015
Status: Revoked; Nov 10, 2023
Publication Date: Mar 17, 2021
External Links: Slate, Register , Google Patents

IP Verse

Method Of Treating Lung Adenocarcinoma

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3134084